Flore is a personalized probiotics company that analyzes your gut microbiome to create customized probiotic formulations. Through microbiome testing and sequencing, they formulate targeted synbiotic products designed to support gut health, immunity, and mood, with offerings for adults, families, and pediatric use. The company operates through a CLIA‑partnered lab network and offers a direct consumer pathway as well as provider partnerships, serving customers primarily in the United States with international programs. Their science-backed approach emphasizes gut health, microbiome balance, and targeted wellness outcomes.
No recent news for this company.
No recent deals for this company.